ROPI
SAVE THE DATE
PROGETTO CANOA CARCINOMA MAMMARIO: QUALI NOVITA’ NEL 2025?
13° EDIZIONE
Verona-Crowne Plaza
29 marzo 2025
PEMBROLIZUMAB PLUS CARBOPLATIN AND PACLITAXEL AS FIRST-LINE THERAPY FOR RECURRENT/METASTATIC...PEMBROLIZUMAB PLUS CARBOPLATIN AND PACLITAXEL AS FIRST-LINE THERAPY FOR RECURRENT/METASTATIC...
